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Pro-inflammatory cytokine release after shock is central in the development of subsequent multiple organ dysfunction syndrome. Some
studies suggest that interleukin-10 (IL-10) is an immunosuppressive mediator after injury or sepsis, while others suggest that IL-10 is an
important regulator of the pro-inflammatory response. We hypothesized that in a model of trauma and hemorrhagic shock (TH), IL-10
regulates pro-inflammatory cytokine activity via an autocrine effect on cytokine mRNA transcription in Kupffer cells early after TH. To study
this, male C3H/HeN mice were sham-operated or subjected to TH. Plasma levels of TNF-a, IL-6 and PGE2 were elevated following TH. A
sharp peak in IL-10 levels was observed at 2 h after the insult. Kupffer cell (KC) depletion prior to TH reduced plasma IL-6, IL-10 and TNF-
a levels, whereas treatment with anti-IL-10 after TH increased IL-6 and TNF-a levels. Kupffer cell mRNA expression for IL-6, IL-10 and
TNF-a was elevated in the TH group and further increased by anti-IL-10 treatment. These findings indicate that KC-dependent IL-10
regulates the early systemic inflammatory response after TH. Thus, while IL-10 is an important mediator of immunosuppression following
traumatic injury, it also is beneficial with regard to its ability to counter-regulate the early inflammatory response under such conditions.
D 2004 Elsevier B.V. All rights reserved.Keywords: Kupffer cell; Immune response; Cytokine; Anti-IL-10; GdCl21. Introduction
Various forms of injury, infection and major surgical
interventions have been shown to activate the primary host
inflammatory response, defined as systemic inflammatory
response syndrome (SIRS) [1]. This exaggerated host in-
flammatory response may be deleterious and contribute to a
subsequent state of immune deactivation, defined as com-
pensatory anti-inflammatory response syndrome (CARS)
[2]. The early release of pro-inflammatory cytokines such
as TNF-a, IL-1h and IL-6 contribute to the development of
multiple organ dysfunction/failure syndrome [3–5]. Several
experimental and clinical studies have shown salutary
effects of agents that suppress the early inflammatory
response under such conditions [6]. Nonetheless, under-0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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activities of cytokines within the cytokine network, the role
of many mediators in the induction or inhibition of immu-
nosuppressive and inflammatory processes associated with
injury is incomplete.
Interleukin-10 (IL-10) is an anti-inflammatory cytokine
that is a potent down-regulator of cell-mediated immune and
pro-inflammatory responses [7–11]. IL-10 was originally
identified as a soluble factor produced by murine, CD4+,
Th2-type T-cell clones that could inhibit production of Th1
cytokines such as IL-2 and interferon-g (IFN-g) that are
associated with cell-mediated immunity [12]. Several stud-
ies demonstrated that IL-10 inhibits the immune respon-
siveness of antigen-presenting cells such as monocytes,
macrophages, and dendritic cells [8,13–15]. In particular,
experimental studies demonstrated that IL-10 inhibited the
production of pro-inflammatory cytokines, such as TNF-a,
IL-1 and IL-6, by activated macrophage [11,16–18]. More-
over, it has been demonstrated that IL-10 is an immune
suppressant in animal models of trauma, hemorrhage, sepsis
and thermal injury [19–21].
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to healthy volunteers suppressed the synthesis of the in-
flammatory cytokines IL-1h and TNF-a by whole blood
stimulated ex vivo with LPS [22]. Moreover, clinical data
suggest that the increased release of IL-10 in injured patients
appears to be an indicator of poor prognosis with higher risk
for infection, multiple organ failure and death [23–26].
Additionally, experimental studies indicate that neutraliza-
tion of IL-10 at a later time point after traumatic injury or
sepsis exerted beneficial effects [21,27]. Additional studies
clearly suggest that elevated levels of IL-10 early post-insult
confer protection following trauma, endotoxemia and sepsis
[28–30]. In view of these diverse findings, we hypothesized
that in a model of trauma and hemorrhagic shock (TH), IL-
10 regulates pro-inflammatory cytokine activity via an
autocrine effect on cytokine mRNA transcription in Kupffer
cells early after TH.2. Materials and methods
2.1. Animals
Inbred male C3H/HeN mice (Charles River Laboratories,
Wilmington, MA), 8–10-weeks old (23-26 g BW), were used
for this study. All procedures were carried out in accordance
with the guidelines set forth in the Animal Welfare Act and
the Guide for the Care and Use of Laboratory Animals by the
National Institutes of Health. The Institutional Animal Care
and Use Committee of the University of Alabama at Birming-
ham approved this study.
2.2. Experimental groups
In the first series of experiments, male mice were
randomized into two groups, subjected to either trauma-
hemorrhage (TH) or sham operation. Blood was collected
during the hemorrhage procedure (i.e., maximum bleed out)
and at various time points after the TH procedure or the
sham operation. Each time point consisted of eight mice
from the TH and sham group. A third group of eight animals
served as a control group that was not subjected to any
manipulation. In a second experimental setup, mice were
randomized into four groups (7–8 mice/group). Groups 1
and 3 mice underwent sham operation, while Groups 2 and
4 mice were subjected to TH. Groups 1 and 2 received
saline intravenously (i.v.; hereafter referred to as vehicle) 48
h prior to the experimental procedure. Groups 3 and 4
received an i.v. injection of gadolinium chloride (GdCl2;
Sigma Chemicals Co., St. Louis, MO) dissolved in saline
(10 mg/kg body weight) 48 h prior to the TH or sham
operation to deplete Kupffer cells [31]. Blood was collected
at 2 h following TH or sham operation. In the third
experimental setup, mice were again randomized into four
groups (7–8 mice/group). Groups 1 and 3 mice underwent
sham operation, while Groups 2 and 4 mice were subjectedto TH. Groups 1 and 2 received 250 Ag/animal rat IgG1/n
isotype-matched negative control (R3-34; NA/LEk; BD
PharMingen, San Diego, CA) intra-arterially (i.a.) at the
time of resuscitation. Groups 3 and 4 received an i.a.
injection of 250 Ag/animal anti-mouse IL-10 monoclonal
antibody (JESS-2A5; NA/LEk; BD PharMingen) at the
time of resuscitation (26–28). Blood, spleen and liver were
collected at 2 h following TH or sham operation.
2.3. Trauma-hemorrhage procedure
Mice were lightly anesthetized with methoxyflurane
(Metofane, Pitman-Moore, Mundelein, IL) and restrained
in a supine position. A 2.5-cm midline laparotomy (i.e.,
induction of soft tissue trauma) was performed, and the
abdominal incision was closed aseptically in two layers
using 6–0 sutures (Ethilon, Ethicon Inc., Somerville, NJ).
Both femoral arteries were then aseptically cannulated with
polyethylene 10 tubing (Clay-Adams, Parsippany, NJ)
using a minimal dissection technique. Heparin (porcine
intestine heparin, Elkins-Sinn Inc., Cherry Hill, NJ), 2 U/
25 g BW, was then administrated and the mice were
allowed to awaken. One of the catheters was attached to
a blood pressure analyzer (Digi-Med BPA-190, Micro-Med
Inc., Louisville, KY) to monitor blood pressure constantly.
Upon awakening, the animals were bled through the other
catheter to a mean arterial blood pressure (BP) of 30F 5
mm Hg (BP pre-hemorrhage was 90F 5 mm Hg), which
was maintained for 90 min. At the end of that period, the
mice were resuscitated with lactated Ringer solution (four
times the shed blood volume for 30 min). Lidocaine
hydrochloride was applied to the groin incision sites, the
catheters were removed, the vessels ligated and the groin
incisions were closed. Sham-operated animals underwent
the same groin dissection, which included ligation of both
femoral arteries; however, neither hemorrhage nor fluid
resuscitation was performed.
2.4. Plasma collection and assessment of plasma cytokine
level
Whole blood was obtained by cardiac puncture and
centrifuged at 16,000 g for 15 min at 4 jC. Plasma
was separated, placed in pyrogen-free microcentrifuge
tubes, immediately frozen, and stored ( 80 jC) until
assayed. Plasma TNF-a, IL-6 and IL-10 levels were
determined using sandwich enzyme-liked immunosorbent
assay (ELISA) technique (PharMingen) according to the
manufacturer’s recommendation. Plasma PGE2 levels were
measured by enzyme immunoassay (Cayman Chemical,
Ann Arbor, MI) according to the manufacturer’s instruc-
tions. In brief, plasma samples were purified by C-18 solid
phase extraction before assay to obviate sample-specific
interferences. Plasma protein content was determined by
colorimetric assay using the Bio-Rad DC Protein Assay
(Bio-Rad, Hercules, CA).
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Kupffer cells were obtained as previously described by
Ayala et al. [32]. In brief, the peritoneal cavity was opened
aseptically, the portal vein exposed, catheterized with a 27-
gauge needle attached and the inferior vena cava was
nicked. The liver was then blanched to remove blood by
perfusion of 20-ml ice cold HBSS without Ca+/Mg+
(Gibco). This was immediately followed by perfusion of
10 ml of 0.075% collagenase class IV (Sigma) in HBSS
without Ca+/Mg+ at 37 jC. The liver was removed (en
bloc) and transferred to a petri dish containing ice-cold
0.075% collagenase in HBSS. After mincing and incuba-
tion at 37 jC for 10 min, the cell suspension was passed
through a sterile 150-mesh stainless steel screen into a 150-
ml beaker containing 10-ml ice cold HBSS and the cell
suspension was washed twice by centrifugation at 400 g
C.P. Schneider et al. / Biochimica24Fig. 1. Effect of TH on plasma levels of inflammatory mediators. Plasma levels of
times during and after (TH) and resuscitation or sham operation as described in M
‘‘control’’ mice and Max represents the time of maximal bleed out during the hemo
point/group. *P < 0.05 as compared with the respective sham value.for 15 min with HBSS. The cells were then resuspended in
Click’s medium containing 10% fetal bovine serum, gen-
tamycin (1 Ag/ml), Penicillin-G 50 U/ml and Streptomycin
50 Ag/ml (Gibco) and layered over 16% Metrizamide
(Accurate Chem. Corp., Westbury, NY) in HBSS and
centrifuged at 1500 g for 45 min. After removing the
non-parenchymal cells from the interface, the cells were
washed twice again by centrifugation at 400 g for 15 min
with PBS containing 1% FCS for flowcytometric analysis
or with complete Click’s. Cells resuspended with complete
Click’s were plated in a 12-well plate at a cell density of
106 cells/ml. After 4-h incubation (37 jC, 95% humidity
and 5% CO2), nonadherent cells were removed by gentle
washing with complete Click’s medium. Viability of
Kupffer cells was consistently >95% as determined by
trypan blue exclusion, regardless of whether or not the
cells were obtained from TH or sham animals. PreviousTNF-a [A], IL-6 [B], IL-10 [C] and PGE2 [D] were determined at various
aterials and methods. C represents cytokine levels in normal unmanipulated
rrhage period. The data are presented as meanF S.E.; n= 8 animals per time
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cols provide adherent cell populations that were greater
than 95% positive by nonspecific esterase staining and
exhibit typical macrophage morphology [32].Fig. 2. Effect of Kupffer cell depletion with GdCl2 on plasma inflammatory
mediator levels following TH. Plasma levels of TNF-a [A], IL-6 [B] and
IL-10 [C] at 2 h after TH or sham operation in vehicle-treated and GdCl2-
treated mice were determined as described in Materials and methods. The
data are presented as meanF S.E.; n= 8 animals/group. *P < 0.05 as
compared with the respective sham value. yP < 0.05 as compared with the
respective vehicle-treated group.
Fig. 3. Effect of IL-10 neutralization on plasma TNF-a and IL-6 levels
following TH. Plasma levels of TNF-a [A] and IL-6 [B] at 2 h after TH or
sham operation in IgG-treated and anti-IL-10-treated mice were determined
as described in Materials and methods. The data are presented as
meansF S.E.; n = 8 animals/group. *P < 0.05 as compared with the
respective sham value. yP< 0.05 as compared with the respective vehicle-
treated group.2.6. Flowcytometric analysis
All antibodies and isotype-specific controls conjugated to
either fluorescein-isothiocyanate (FITC) or phycoerythrin
(PE) were purchased from PharMingen. The following anti-
bodies and isotype-specific controls were used: 2.4G2 [Rat
(Sprague–Dawley) IgG2b,n; anti-CD16/CD32-NA/LEk, Fc
Blockk], M1/70 [Rat (DA) IgG2b,n; anti-CD11b-FITC], and
1B1.3a [Rat IgG1,n; anti-IL-10 Receptor-PE]. Kupffer cells
were resuspended in PBS containing 1% FCS and 0.1%
sodium azide (complete PBS) and incubated for 15 min in
the presence of 1 Ag/1 million cells of anti-CD16/CD32 to
block Fc-mediated binding. Cells were then double labeled
with anti-CD11b-FITC and anti-IL-10 receptor-PE or with
corresponding control antibodies (1 Ag of antibody per 106
cells). Samples were incubated for 30 min on ice in the dark
and thereafter washed once with complete PBS. For the
second step, cells were incubated with streptavidin-PE
(1:200) for 30 min in the dark at room temperature and
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ice in the dark and all measurements were analyzed within
30 min after completing the staining procedure. FITC and
PE were analyzed with a Becton-Dickinson FACSort flow
cytometer (San Jose, CA) fitted with a 488-nm argon laser
and filter settings for FITC (530-nm-wide bandpass filter)
and PE (575-nm dichronic filter). After appropriate instru-
ment settings and spectral compensations, the instrument
settings were not changed and stability was checked
regularly. A minimum of 15,000 events was assessed using
log-amplified fluorescence signals and linearly amplified
side- and forward-scatter signals. PC-lysis Ver.1.0 software
(Becton-Dickinson) was used to analyze the data.
2.7. Western blot analysis
Kupffer cells were purified by culture for 2 h in complete
media. Nonadherent cells were removed by washing five
times with PBS. Adherent cells were collected and washed
in ice-cold Tris-buffered saline (TBS; 137 mM NaCl, 5 mM
KCl and 25 mM Tris, pH 7.4) and resuspended in 1-ml
TBS, transferred to Eppendorf tubes and centrifuged for 15 s
at 12,000 g at 4 jC according to the procedures ofFig. 4. Effect of IL-10 neutralization on Kupffer cell IL-10, TNF-a and IL-6 mRNA
a and IL-6 at 2 h after TH or sham operation in IgG-treated and anti-IL-10-treate
shown above are from a representative experiment [A] and densometric analysis
meansF S.E.; n= 4 animals/group. *P < 0.05 as compared with respective shamSchreiber et al. [39]. Supernatants were aspirated and pellets
were resuspended in 400-Al ice-cold Buffer A (10 mM
HEPES, pH 7.9; 10 mM KCl; 0.1 mM EDTA, pH 8.0;
0.1 mM EGTA, pH 8.0; 1 mM DTT; 0.5 mM PMSF; 50 mM
sodium-fluoride; 10 mM sodium-pyrophospate; 1 mM so-
dium-orthovanadate and complete protease inhibitor mix-
ture; Boehringer, Lewes, UK). After 15-min incubation on
ice, 25-Al 10% Ipegal (Sigma) was added and samples were
vortexed for 10 s, followed by centrifugation at 12,000 g
for 30 s. Supernatants containing the cytosolic fraction were
aliquoted and stored at  80 jC until analysis. Cytosolic
extract protein content was determined by colorimetric
assay using the Bio-Rad DC Protein Assay (Bio-Rad).
The following antibodies were used: mouse monoclonal
anti-STAT3 (p92) and mouse monoclonal anti-pSTAT3
(Tyr-705) (Santa Cruz Biotech, Santa Cruz, CA). The
reaction mixture for immunoprecipitation consisted of 5-
Ag protein from the cytosolic extract, 5-Ag antibody and
buffer A to a final volume of 400 Al. After vortexing and
incubation at 4 jC for 2 h, 200 Al of 10% protein A-
Sepharose CL-4B (Amersham Pharmacia Biotech., Uppsala,
Sweden) was added. The reaction mixture was vortexed and
incubated with agitation at 4 jC for an additional 1 h, thenexpression following TH. Kupffer cell mRNA expression for IL-10, TNF-
d mice were determined as described in Materials and methods. The results
expressed as the ratio of target/gene/h-actin [B]. The data are presented as
value. yP< 0.05 as compared with respective vehicle-treated group.
Fig. 5. Effect of IL-10 neutralization on Kupffer cell IL-10R expression
following TH. Kupffer cell expression for IL-10R at 2 h after TH or sham
operation in IgG-treated and anti-IL-10-treated mice was determined by
FACS analysis as described in Materials and methods [A]. The mRNA
expression for IL-10R1and IL-10R2 shown above is from a representative
experiment [B] and densometric analysis expressed as the ratio of target/
gene/h-actin [C]. The data are presented as meansF S.E.; n= 4 animals/
group. *P < 0.05 as compared with respective sham value. yP< 0.05 as
compared with respective vehicle-treated group.
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A and three times with PBS. The pellet was suspended in 50
Al of 1 Laemmli sample buffer (Novex, San Diego, CA),
boiled for 15 min at 90 jC, centrifuged, and the supernatant
was used for electrophoretic analysis. Electrophoresis was
performed on precast 4–10% Bis-Tris polyacrylamide gels
in 4-morpholinepropanesulfonic acid running buffer con-
taining 10% sodium dodecyl sulfate (Novex) for 45 min at a
constant 200 V. Western transfers to nylon membranes
(Novex) were carried out according to the manufacturer’s
instructions. The membranes were probed by reacting with
specific antisera, and protein bands were detected by using
SuperSignalR West Dura Western Blotting Kit (Pierce,
Rockford, IL). The images for typical blots, repeated at
least three times, were captured using a gel documentation
system (ChemiImager, Alpha Inotech Corporation, San
Leandro, CA).
2.8. RT-PCR analysis
Total RNA was prepared from Kupffer cells using
denaturing solution (Clontech, Palo Alto, CA) followed by
three rounds of phenol/chloroform and chloroform/isoamyl
alcohol (Sigma) extraction [33]. RNA was precipitated with
isopropanol and washed with 80% ethanol. After air-drying,
the pellet was resuspended in DEPC-treated water. Total
RNA concentration and purification was determined by
measuring the absorbance at 260 and 280 nm. RNA (1
Ag) was reverse-transcribed (RT) in 20-Al reaction volume
containing 1 RT reaction buffer (50 mM Tris–HCl, pH
8.3; 75 mM KCl; 3 mM MgCl2), 0.5 mM dNTP, 20 U
RNase inhibitor, 20 pM oligo(dT)18 primer, and 200 U
reverse transcriptase (Clonetech, Palo Alto, CA). The RT
reaction was incubated at 42 jC for 1 h, followed by heating
at 94 jC for 5 min. The cDNA was diluted with 80-
Al DEPC-treated water and stored at  80 jC before
undergoing PCR.
Primers for mouse IL-6, IL-10 and h-actin were pur-
chased from Clonetech and the primer for TNF-a was
purchased from Ambion (Austin, TX). The primer sequences
for IL-10R1, 5VAGG CAG AGG CAG CAG GCC CAG
CAG AA 3V(forward), 5VTGG AGC CTG GCTAGC TGG
TCA CAG 3V(reverse); IL-10R2; 5VGCC AGC TCT AGG
AAT GAT TC 3V(forward), 5VAAT GTT CTT CAA GGT
CCA C 3V(reverse); and SOCS-3, 5VGGA CCA GCG CCA
CTT CTT CAC 3V (forward), 5VTAC TGG TCC AGG AAC
TCC CGA 3V (reverse) were custom synthesized by Life
Technologies, Inc. (Gaithersburg, MD) [40]. Ten percent
portions of cDNA were amplified with 0.4 AM each of 3V
and 5V primers or G3PDH primers (Clonetech), in 50 Al of
PCR mixture containing 1 buffer (50 mM KCl; 10 mM
Tris-HCl and 1.5 mM MgCl2), 0.2 mM dNTP mix, 2.5 U
AmpliTaq DNA polymerase (Clonetech). Thirty-six cycles
of amplification were performed using a ‘‘MastercyclerR
gradient’’ (Eppendorf AG, Hamburg, Germany) in thin-
walled 0.2-ml PCR tubes (Eppendorf) according to thefollowing protocol: First cycle of 95 jC (3 min), 60 jC
(2 min), and 72 jC (3 min) followed by 34 cycles of 95 jC
(40 s), 60 jC (1 min) and 72 jC (1 min). A final 5-min
incubation at 72 jC was used to ‘‘polish’’ the DNA termini.
The resulting amplicons (TNF-a 239 bp, IL-6 638 bp, IL-10
455 bp, IL-10R1 508 bp, IL-10R2 400 bp, SOCS-3 450 bp
and h-actin 540 bp) were resolved on ethidium bromide-
stained (0.5 Ag/ml) 1.8% TBE-agarose gels and photo-
graphed using a gel documentation system (ChemiImager,
Alpha Inotech). The amount of PCR products generated by
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ChemiImager System (Alpha Inotech). The results of typical
experiments, repeated no less than three times, are presented.
2.9. Statistics
Data are presented as the meanF S.E. of seven to eight
animals in each group. One-way Analysis of Variance
(ANOVA) followed by Tukey’s test was employed to
determine the significance of the differences between ex-
perimental means. A P value of < 0.05 was considered
significant for all statistical analyses.3. Results
3.1. Effect of TH on plasma inflammatory mediator levels
TH induced a significant increase in the plasma levels of
TNF-a, IL-6, IL-10, and PGE2 (Fig. 1). TNF-a and IL-6Fig. 6. Effect of IL-10 neutralization on Kupffer cell STAT3 and SOCS-3 mRNA
(pSTAT3) [A] and STAT3 [B] and mRNA expression for SOCS-3 [C] 2 h afte
determined as described in Materials and methods. The Western blot results for S
densometric analysis expressed as the arbitrary units [B]. The mRNA expressio
densometric analysis expressed as the ratio of target/gene/h-actin [D]. The data are
the respective sham value. yP < 0.05 as compared with the respective vehicle-trealevels were already significantly elevated at the end of TH
and resuscitation (Fig. 1A–B). While TNF-a remained
increased only until 8 h after resuscitation, IL-6 plasma
levels remained significantly elevated until 36 h after
resuscitation. Early after resuscitation, plasma concentra-
tions of IL-10 were significantly increased, reaching a
maximum at 2 h after TH and resuscitation (Fig. 1C).
However, the elevated plasma IL-10 level returned to
baseline level at 4 h after TH and remained at that level
until the end of the observation period. In contrast, plasma
levels of PGE2 were not significantly increased until 6
h after resuscitation and remained elevated for the entire
study period, i.e., 48 h (Fig. 1D).
The results shown in Fig. 2 indicate that depletion of
Kupffer cells in mice by gadolinium chloride (GdCl2) treat-
ment prior to TH profoundly and significantly suppressed the
TH-induced increase in the plasma concentrations of TNF-a,
IL-6 and IL-10 normally observed in untreated (Fig. 1) or
vehicle-treated mice (Fig. 2). Plasma PGE2 levels were
undetectable at 2 h after TH (data not shown).expression following TH. Kupffer cell expression of phosphorylated STAT3
r TH or sham operation in IgG-treated and anti-IL-10-treated mice were
TAT expression shown above are from a representative experiment [A] and
n for SOCS-3 shown above is from a representative experiment [C] and
presented as meansF S.E.; n= 4 animals/group. *P< 0.05 as compared with
ted group.
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(anti-IL-10) at the time of resuscitation resulted in signifi-
cantly increased plasma levels of TNF-a and IL-6 at 2
h following TH as compared to animals receiving control
IgG under such conditions (Fig. 3). Sham animals treated
with anti-IL-10 displayed similar plasma cytokine levels as
those from the sham IgG treatment group.
3.2. Effect of TH on Kupffer cell cytokine gene transcription
Determination of IL-10, TNF-a, and IL-6 at the level of
mRNA expression showed a significant elevation for IL-10
and TNF-a mRNA expression by control IgG-treated mice
after TH as compared to their respective sham group (Fig.
4). Neutralization of IL-10 with anti-IL-10 treatment during
resuscitation significantly increased TNF-a mRNA expres-
sion by Kupffer cells from both sham and TH mice. Anti-IL-
10 treatment also markedly increased IL-6 and IL-10
expression in the TH group, but not the sham group as
compared with IgG treated mice. A similar gene expression
pattern was observed in mice not treated with IgG and
subjected to sham operation or TH (data not shown).
3.3. Effect of TH on Kupffer cell IL-10 receptor (IL-10R)
transcription
TH did not significantly alter IL-10R surface expression
on CD11b+ Kupffer cells as determined by FACS analysis
(Fig. 5A). Additionally, the expression of IL-10R on
Kupffer cells from either sham or TH mice was unaltered
by treatment with anti-IL-10. The mRNA expression of IL-
10R1 and IL-10R2 by Kupffer cells is shown in Fig. 5B–C.
The mRNA expression for the IL-10R1 was decreased in
Kupffer cells from TH mice treated with IgG as compared to
respective sham group. In contrast, expression for the IL-
10R2 was elevated in Kupffer cells from IgG-treated mice
subjected to TH. Treatment with anti-IL-10 significantly
increased mRNA expression for IL-10R1 in Kupffer cells
from both sham and TH mice, whereas anti-IL-10 treatment
did not alter IL-10R2 mRNA expression by sham cells, but
significantly increased expression in Kupffer cells from TH
mice.
3.4. Effect of TH on Kupffer cell STAT-3 activation and
suppressor of cytokine signaling-3 (SOCS-3) transcription
Kupffer cells demonstrated constitutive expression of
STAT3, which was unaffected by TH and IL-10 inhibition
(Fig. 6). Kupffer cells also demonstrated constitutive ex-
pression of pSTAT3, which was slightly induced by TH, but
was unaffected by IL-10 inhibition (Fig. 6). Increased
pSTAT-3 expression following TH was not associated with
an increase in SOCS-3 mRNA expression by Kupffer cells
(Fig. 6C–D). In contrast, anti-IL-10 treatment increased
SOCS-3 expression in both the sham and TH groups as
compared to respective IgG-treated mice.4. Discussion
The precise nature of the role of IL-10 following
traumatic injury, shock and/or sepsis remains controversial.
On one hand, experimental and clinical studies suggest that
IL-10 is deleterious due to its ability to suppress cell-
mediated immune responses [19–21,23–25], while on the
other hand, studies have suggested that IL-10 has a
beneficial effect on outcome post-injury [26,34,35]. The
early phase of the host response after traumatic injuries and
hemorrhagic shock is characterized by increased circulating
levels of various inflammatory mediators (1–6) and our
present results indicate that beside increased circulating
levels of TNF-a and IL-6, elevated levels of IL-10 were
also detectable early post-injury. Plasma IL-10 levels
showed a peak at 2 h post-resuscitation, returning to
baseline at 4 h after resuscitation. Similarly recent animal
models of ischemia-reperfusion injury have also shown a
similar early increase (2 h post-reperfusion) in systemic and
tissue levels of IL-10 levels [36,37]. In addition, Barsig et
al. [38] have shown that LPS induces a biphasic IL-10 time
course with peaks at 1.5 and 8–12 h that is regulated by
endogenous TNF-a. In contrast, other experimental models
of traumatic injury and sepsis detected elevated IL-10
plasma levels as late as 21 days after the initial insult
[24,26,39]. Whether this difference in the timing of the
peak IL-10 release is due to the difference in the severity of
the insult, i.e., TH versus sepsis/LPS, remains to be
determined. Nonetheless, with regard to the timing of the
IL-10 peak, studies by Song et al. [34] indicate that early
blockade of IL-10 in a rodent model of sepsis was not
beneficial, whereas blockade later (12 h) improved surviv-
al. Additionally, studies in a burn model of immune
suppression indicate that delayed inhibition of IL-10 is
beneficial [35], whereas early blockade (i.e., IL-10 defi-
cient mice) was detrimental under such conditions [40].
Our finding here in conjunction with previous studies
described above supports the concept that early IL-10
responses are important in dampening the inflammatory
response post-injury.
Previous studies have shown that the release of inflam-
matory mediators early following trauma, sepsis and LPS is
macrophage-mediated, particularly by hepatic macrophages
or Kupffer cells [5,38,41,42]. Our results indicate that
Kupffer cells are also the major contributor to the elevation
in plasma IL-10 levels early after TH. Plasma levels of PGE2,
which represent another important counter-regulator of mac-
rophage immune response [43,44], started to increase 6 h after
TH and after IL-10 plasma levels had normalized. This
suggests that the suppressive effects of this ecosinoid on
cell-mediated immune responses under such conditions
might be independent of macrophage IL-10. A number of
studies have also shown that IL-10 is capable of inhibiting the
production of macrophage derived pro-inflammatory cyto-
kines [6,11,15,16,34]. The observation that macrophages
produce IL-10 early after TH suggests that IL-10 may be an
C.P. Schneider et al. / Biochimica et Biophysica Acta 1689 (2004) 22–3230important autocrine regulator of pro-inflammatory macro-
phage activity. In this regard, we propose that Kupffer cell-
derived IL-10 acts in an autocrine manner to attenuate the
pro-inflammatory immune response by this macrophage
population following TH. Support for this suggestion came
from our studies, which showed that blockade of IL-10 with
antibodies enhanced the production of both TNF-a and IL-6.
These findings are consistent with those of others examining
IL-10 and macrophage function under both normal and
pathological conditions [11,15]. Studies also suggest that
the inhibitory effect of IL-10 on macrophage pro-inflamma-
tory cytokines is at the level of gene expression due to
decreased transcription [16,45,46]. Our findings support this
concept since treatment with anti-IL-10 resulted in increased
expression of mRNA for IL-6. Inhibition of TNF-a occurred
at the level of mRNA transcription as well as at the level of
protein expression, since the induction of TNF-a mRNA by
TH and the increase of TNF-a mRNA by IL-10 blockade in
sham animals are similar to those seen in the TH and IL-10
blockade group. Interestingly, only low levels of IL-10
mRNA expression were evident in Kupffer cells at 2 h after
TH, suggesting that IL-10 mRNA expression was already
down-regulated. Similar observations were made by Knolle
et al. [47] showing that preincubation of resting Kupffer cells
with IL-10, before an endotoxin challenge, led to almost total
inhibition of subsequent IL-10 gene expression. In accor-
dance with those results, administration of anti-IL-10 at the
time of resuscitation significantly increased IL-10 mRNA
expression. This increase in IL-10 mRNA is likely related to
the abrogation of product feedback inhibition on gene ex-
pression by anti-IL-10.
It has been demonstrated that IL-10R expression is
constitutive and functional in Kupffer cells as well as other
immune cell populations [13,47,48]. Our results are consis-
tent with those findings. Functional IL-10R complexes are
tetramers consisting of two IL-10R1 polypeptide chains and
two chains of the newly identified molecule known as
CRF2-4 (i.e., IL-10R2) [49]. These investigators showed
that expression of the IL-10R1 chain alone was not suffi-
cient to transduce IL-10-mediated signals; however, co-
expression of IL-10R1 together with CRF2-4 resulted in
the formation of functional IL-10R complexes that were
able to bind and respond to IL-10. The constant expression
of IL-10R1 mRNA by Kupffer cells might be explained by
the anatomical location of this macrophage population in the
liver and its continued exposure to gut-derived activating
stimuli. Recent findings indicate that up-regulation of IL-
10R1 expression was required to render neutrophils fully
responsive to IL-10 [50]. Moreover, binding of IL-10 to IL-
10R1 activates phosphorylation of receptor associated
kinases (JAK1 and Tyk2) leading to receptor phosphoryla-
tion and STAT3 association and activation [10]. Finding by
Ding et al. [51] suggest that modulation of cell surface
expression of IL-10R1 might be an important mechanism
for determining whether or not IL-10 is immunosuppressive
or immunostimulatory. In the current study, IL-10R1 mRNAexpression was down-regulated in Kupffer cells following
TH, suggesting that Kupffer cell-derived IL-10 had attenu-
ated IL-10R1 expression. Accordingly, IL-10 blockade with
antibodies elevated IL-10R1 and IL-10R2 mRNA expres-
sions but not IL-10 receptor surface expression. In this
regard, studies have shown that IL-10R2 expression is
required for IL-10 biological effect [49].
It has been recently demonstrated that STAT3 plays a
critical role in mediating IL-10-induced inhibition as shown
by targeted deletion of the STAT3 gene in macrophage and
neutrophils [10,52]. Our study indicated that the phosphor-
ylated STAT (pSTAT3) expression was high in Kupffer cells
from sham mice. Trauma-hemorrhage slightly, but statisti-
cally significantly, increased pSTAT3 independent of vari-
ation in the amount of circulating IL-10. Thus, the elevated
pSTAT3 in Kupffer cells from trauma-hemorrhaged mice
might be playing an important role in mediating IL-10-
induced inhibitory effects. Moreover, IL-10 rapidly induces
expression of a novel gene known as SOCS-3 in monocytes
[53]. SOCS-3 is a member of a newly identified family of
highly conserved genes that mediate feedback inhibition of
cytokine-induced responses [54,55]. Recent data have indi-
cated that SOCS-3 is involved as a mediator of inhibitory
effects of IL-10 on macrophage activation [56], as well as
IL-10-mediated immune responses [57]. Ogle et al. [58]
demonstrated that thermal injury induced an elevation in
SOCS-3 expression in the whole liver. In contrast, we did
not observe a significant increase in mRNA expression of
SOCS-3 by Kupffer cells following TH and resuscitation.
In summary, the present results indicate that IL-10 plays a
crucial role as a regulator of the early inflammatory immune
response after TH. The present findings also indicate that
Kupffer cells represent the major cellular source of elevated
circulating IL-10 levels under such conditions. Furthermore,
our studies indicate that the pro-inflammatory response of
this macrophage population is under autocrine control by IL-
10. Although other studies have clearly demonstrated that
binding of IL-10 to its receptor led to STAT3 phosphoryla-
tion and subsequently induced SOCS3 [10], our findings
suggest that it appears to be independent of the pSTAT3/
SOCS-3 signal transduction pathway.Acknowledgements
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